MedCheck: Zunveyl for Alzheimer’s, Erzofri for Schizophrenia, Gene Therapy and Parkinson's, and more
FDA Approves Zunveyl for Mild to Moderate Alzheimer’s Disease
Erzofri Approved for Schizophrenia, Schizoaffective Disorder in Adults
Investigational Gene Therapy Gets Fast-Tracked for Parkinson’s Disease
FDA Requests More Data on OX124 for Opioid Overdose Reversal
FDA Fast Tracks Two Potential Therapies for Alzheimer’s Disease
Information & Authors
Information
Published In
History
Keywords
- fda
- food and drug administration
- zunveyl
- benzagalantamine
- galantamine
- alzheimers disease
- alpha cognition
- alpha 1062
- erzofri
- paliperidone
- paliperidone palmitate
- schizophrenia
- schizoaffective disorder
- luye pharma
- invega
- gene therapy parkinsons
- parkinsons disease
- ab 1005
- askbio
- lomecel b
- longeveron
- jnj 2056
- aci 35 030
- ac immune
- phosphorylated tau
- ox124
- orexo
- opioid overdose
- naloxone
- high dose naloxone
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
Get Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).